Bristol-Myers Squibb Company
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
FY2007
Total Cash from Operations: $14.16B
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $412.5M | 2.9% |
| Business Acquisitions | $1.24B | 8.8% |
| Dividends Paid | $1.96B | 13.8% |
| Other Financing | $1.69B | 11.9% |
| Other | $8.85B | 62.5% |
| Net Cash Flow | $0 | 0.0% |